A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group. [electronic resource]
Producer: 20000124Description: 2397-404 p. digitalISSN:- 0269-9370
- Adjuvants, Immunologic -- administration & dosage
- Administration, Topical
- Adult
- Aminoquinolines -- administration & dosage
- CD4 Lymphocyte Count
- Condylomata Acuminata -- complications
- Double-Blind Method
- Drug Eruptions -- etiology
- Female
- HIV Infections -- complications
- Humans
- Imiquimod
- Male
- Middle Aged
- Prospective Studies
- Safety
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.